Functional role of fractalkine (CX3CL1) in rheumatoid arthritis.

被引：0
|
作者：
Blaschke, S
Koziolek, M
Schwarz, A
Benöhr, P
Middel, P
Schwarz, G
Hummel, KM
Müller, GA
机构：
[1] Univ Gottingen, D-3400 Gottingen, Germany
[2] Univ Dresden, Dresden, Germany
来源：
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
638
引用
收藏
页码：S278 / S278
页数：1
相关论文
共 50 条
  • [21] Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis
    Matsunawa, Mizuho
    Isozaki, Takeo
    Odai, Tsuyoshi
    Yajima, Nobuyuki
    Takeuchi, Hiroko T.
    Negishi, Masao
    Ide, Hirotsugu
    Adachi, Mitsuru
    Kasama, Tsuyoshi
    ARTHRITIS AND RHEUMATISM, 2006, 54 (11): : 3408 - 3416
  • [22] The Chemokine CX3CL1 (Fractalkine) and its Receptor CX3CR1: Occurrence and Potential Role in Osteoarthritis
    Piotr Wojdasiewicz
    Łukasz A. Poniatowski
    Andrzej Kotela
    Jarosław Deszczyński
    Ireneusz Kotela
    Dariusz Szukiewicz
    Archivum Immunologiae et Therapiae Experimentalis, 2014, 62 : 395 - 403
  • [23] THE MATERNAL-TO-FETAL KINETIC ANALYSIS OF FRACTALKINE/CX3CL1
    Chang, Y. S.
    Ishii, H.
    Nakai, Y.
    Ishida, T.
    Fuke, S.
    Maeda, T.
    Nakamura, T.
    Shimoya, K.
    PLACENTA, 2012, 33 (09) : A135 - A135
  • [24] Expression of Fractalkine (CX3CL1) in Patients with Psoriasis and Atopic Dermatitis
    Azzam, Omar
    Leheta, Tahra
    Hay, Rania Abdel
    Fawzy, Marwa
    El Tawdy, Amira
    Rashed, Laila
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S84 - S84
  • [25] Syk is required for monocyte/macrophage chemotaxis to CX3CL1 (fractalkine)
    Gevrey, JC
    Isaac, BM
    Cox, D
    JOURNAL OF IMMUNOLOGY, 2005, 175 (06): : 3737 - 3745
  • [26] CX3CL1 (Fractalkine): An important cytokine in physiological and pathological pregnancies
    Hu, Xianyang
    Huang, Xixi
    Yin, Tingxuan
    Chen, Jiajia
    Zhao, Weijie
    Yu, Min
    Liu, Lu
    Du, Meirong
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2024, 166
  • [27] Elevation of fractalkine (CX3CL1) after coronary stent implantation
    Tanaka, S.
    Muraoka, Y. M. Yoshitake
    Sonoda, S. S. Shinjo
    Otsuji, Y. O. Yutaka
    EUROPEAN HEART JOURNAL, 2010, 31 : 1025 - 1025
  • [28] POSSIBLE ROLE OF FRACTALKINE/CX3CL1 (FKN) IN THE MICROVASCULAR DAMAGE OF SYSTEMIC SCLEROSIS (SSC)
    Stefanantoni, K.
    Sciarra, I.
    Corinaldesi, C.
    Caucci, M.
    Vasile, M.
    Iannace, N.
    Saturno, M. C.
    Crescioli, C.
    Valesini, G.
    Riccieri, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 958 - 959
  • [29] Characterisation of fractalkine/CX3CL1 and fractalkine receptor (CX3CR1) expression in abdominal aortic aneurysm disease
    Patel, A.
    Jagadesham, V. P.
    Porter, K. E.
    Scott, D. J. A.
    Carding, S. R.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2008, 36 (01) : 20 - 27
  • [30] Expression of fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in the trigeminal ganglia: implications for craniofacial nociception
    Gazerani, P.
    Cairns, B. E.
    Dong, X. D.
    JOURNAL OF HEADACHE AND PAIN, 2014, 15
12345